We are live on ! Find out more
HPCM

High Pointe Capital Management Portfolio holdings

AUM $139M
1-Year Est. Return 24.99%
This Fund
S&P 500
This Quarter Est. Return
+4.45%
1 Year Est. Return
+24.99%
3 Year Est. Return
+92.38%
5 Year Est. Return
+133.03%
10 Year Est. Return
AUM
$275M
AUM Growth
+$16M
Cap. Flow
+$5.25M
Cap. Flow %
1.91%
Top 10 Hldgs %
16.68%
Holding
177
New
20
Increased
71
Reduced
11
Closed
21

Sector Composition

Rank Sector Weight
1 Technology 18.37%
2 Healthcare 15.02%
3 Industrials 12.88%
4 Consumer Discretionary 11.88%
5 Financials 9.45%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
TEL icon
76
TE Connectivity
TEL
$59.3B
$1.91M 0.7%
30,850
RRC icon
77
Range Resources
RRC
$8.64B
$1.91M 0.69%
21,920
+70
+0.3% +$6.26K
TDW icon
78
Tidewater
TDW
$3.75B
$1.88M 0.68%
1,035
+12
+1% +$19.9K
FDX icon
79
FedEx
FDX
$73.1B
$1.86M 0.68%
12,270
CCL icon
80
Carnival Corporation Ltd
CCL
$35.7B
$1.82M 0.66%
48,450
CKH
81
DELISTED
Seacor Holdings Inc.
CKH
$1.82M 0.66%
22,903
+258
+1% +$20.6K
BBG
82
DELISTED
Bill Barrett Corp
BBG
$1.82M 0.66%
67,850
+800
+1% +$20.4K
AMGN icon
83
Amgen
AMGN
$197B
$1.79M 0.65%
15,150
RHT
84
DELISTED
Red Hat Inc
RHT
$1.79M 0.65%
32,350
FCX icon
85
Freeport-McMoran
FCX
$84.5B
$1.78M 0.65%
48,750
CAB
86
DELISTED
Cabela's Inc
CAB
$1.77M 0.65%
+28,450
New +$1.8M
IBM icon
87
IBM
IBM
$200B
$1.7M 0.62%
9,780
SZYM
88
DELISTED
SOLAZYME INC COM STK (DE)
SZYM
$1.68M 0.61%
142,150
NVS icon
89
Novartis
NVS
$285B
$1.63M 0.59%
20,043
+201
+1% +$15.8K
NKTR icon
90
Nektar Therapeutics
NKTR
$2.19B
$1.55M 0.56%
+8,040
New +$1.42M
ABT icon
91
Abbott
ABT
$177B
$1.49M 0.54%
36,450
WCC
92
WESCO International
WCC
$15.5B
$1.46M 0.53%
16,950
BBSI icon
93
Barrett Business Services
BBSI
$984M
$1.46M 0.53%
+123,800
New +$1.57M
INFA
94
DELISTED
INFORMATICA CORP
INFA
$1.45M 0.53%
40,600
GILD icon
95
Gilead Sciences
GILD
$165B
$1.43M 0.52%
17,250
CNQ icon
96
Canadian Natural Resources
CNQ
$91.7B
$1.37M 0.5%
61,643
LAB icon
97
Standard BioTools
LAB
$333M
$1.37M 0.5%
+46,450
New +$1.49M
MBII
98
DELISTED
Marrone Bio Innovations, Inc.
MBII
$1.32M 0.48%
+113,500
New +$1.29M
SNY icon
99
Sanofi
SNY
$105B
$1.3M 0.47%
24,410
+600
+3% +$31.8K
CS
100
DELISTED
Credit Suisse Group
CS
$1.26M 0.46%
44,333
+200
+0.5% +$6.12K

Similar funds

High Pointe Capital Management's Q2 2014 Portfolio in Review

As of Q2 2014, High Pointe Capital Management held 177 positions worth $275M, up 6.2% from $259M the previous quarter. Its ten largest holdings account for 17% of the portfolio.

High Pointe Capital Management's Q2 2014 filing shows 20 new, 71 increased, 11 reduced and 21 closed positions. Its largest new stake was Home Depot: 41,600 shares worth $3.37M. The largest sale was FOREST LABORATORIES INC, an estimated $4.19M.

By sector, the portfolio is most concentrated in Technology at 18% of assets, down from 19% a quarter earlier, followed by Healthcare and Industrials.

  • High Pointe Capital Management's largest Q2 2014 buy was Home Depot: 41,600 shares worth $3.37M.
  • High Pointe Capital Management added most to EMC CORPORATION in Q2 2014, an estimated $2.6M increase.
  • High Pointe Capital Management's biggest Q2 2014 reduction was FOREST LABORATORIES INC, cutting an estimated $4.19M.
  • High Pointe Capital Management fully exited Charles River Laboratories in Q2 2014, selling an estimated $3.32M.
  • High Pointe Capital Management's ten largest holdings make up 17% of its $275M portfolio in Q2 2014.
  • High Pointe Capital Management opened 20 new positions and closed 21 in Q2 2014.
  • High Pointe Capital Management's portfolio value rose 6.2% quarter-over-quarter to $275M.

Based on High Pointe Capital Management's 13F filing for Q2 2014, filed 25 Jul 2014.